
27 Sep 2005
ISP showcases latest innovations in Madrid
International Specialty Products (ISP), a leading manufacturer of high quality excipients and provider of drug solubilization services to the pharmaceutical industry globally, will showcase its full portfolio of products and solutions at this year’s Convention of Pharmaceutical Ingredients (CPhI) in Madrid from November 1st – 3rd, 2005. Recent innovations from both ISP Pharmaceutical and Fine Chemicals divisions will be on display at stand 10C28, Hall 10.
ISP produces more than 30 ingredients for use in pharmaceutical formulations, including Plasdone® high-performance binders and solubilizers for tablets, injectables and ophthalmic formulations and Polyplasdone® superdisintegrants for solid dosage forms. The range of products offered by ISP also includes CAVAMAX® native Cyclodextrin products, used in a variety of pharmaceutical applications including bioavailability enhancement of poorly soluble API’s.
Also present will be ISP Pharma Technologies, offering a full service, from development through scale up to commercial manufacture, of solid, spray dried dispersions or solutions, which results in stable drug systems with 5 – 50 fold increases in bioavailability. The ISP Fine Chemicals division manufactures a range of penultimate intermediates and active pharmaceutical ingredients in accordance with cGMP guidelines.
Reader enquiries
International Specialty Products - ISP
Sean Appleton
Communications Manager - Europe
ISP Europe
Waterfield, Tadworth
Surrey, KT20 5HQ
United Kingdom
Notes for editors
About ISP
International Specialty Products Inc. (ISP) is a leading global supplier of specialty chemicals and performance-enhancing products for a wide variety of personal care, pharmaceutical, food, beverage and industrial applications. ISP produces more than 400 specialty chemicals which it markets and sells worldwide. The company's headquarters is located in Wayne, New Jersey, USA.
For more information about ISP’s range of pharmaceutical and fine chemical products, please visit the ISP web site at www.ispcorp.com.
For further information, please visit www.ispcorp.com.
CAVAMAX® is a registered trademark of Wacker-Chemie GmBH. CAVAMAX® cyclodextrins are manufactured by Wacker and marketed by ISP throughout the world (except Japan). This press release may contain “forward-looking” statements within the meaning of the US federal securities laws and, as such, concerns matters that are not historical facts. These statements are subject to risks and uncertainties that could cause the actual results to differ materially from those expressed in such statements. Important factors that could cause such differences are discussed in filings made by ISP Chemco Inc., a subsidiary of International Specialty Products Inc., with the U.S. Securities and Exchange Commission and are incorporated herein by reference.
Editorial enquiries
Sean Appleton
International Specialty Products - ISP
Nathalie Chaimbault
EMG